News
Stocks of the hour: Adherium, Nanoveu, Nimy Resources
To register for today’s webinar, click here.
Adério (ASX:ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, today announced that AstraZeneca has selected its Hailie® Smartinhaler® platform for a clinical trial. This contract is valued at US$1.1 million over three years. Shares are trading 31.58% higher at 2.5 cents.
Nanoveu (ASX:NVU), a company specializing in innovative films and coatings is pleased to announce the execution of a joint venture agreement with its Chinese manufacturing partner Shenzhen Fullsand Printing & Packaging Co. The joint venture was established to develop and commercialize the software and processes of manufacturing by Fullsand owned by Nanoveu. EyeFly3D™ software and focus on global markets excluding China. Shares are trading 5.26% higher at 2 cents.
Nimy Features (ASX:NIM) reports that GAP Geophysics has commenced work on site conducting DHEM, MLEM and FLEM surveys at Masson, Block 3 and Vera’s Gossan Prospects. Fender Geophysics is scheduled to arrive on site on May 29 to conduct a Gradient Array-induced polarization survey at Prospect Block 3. Shares are trading 17.5% higher at 4.7 cents.